Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives

A series of 6,14-dideoxynaltrexones that contain different electrophiles in the 6-position were synthesized and evaluated for nonequilibrium opioid antagonist activity in the guinea pig ileum and mouse vas deferens preparations. Members 3-5 of the series possessed irreversible antagonist activity pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1987-06, Vol.30 (6), p.1040-1044
Hauptverfasser: Schoenecker, J. W, Takemori, A. E, Portoghese, P. S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1044
container_issue 6
container_start_page 1040
container_title Journal of medicinal chemistry
container_volume 30
creator Schoenecker, J. W
Takemori, A. E
Portoghese, P. S
description A series of 6,14-dideoxynaltrexones that contain different electrophiles in the 6-position were synthesized and evaluated for nonequilibrium opioid antagonist activity in the guinea pig ileum and mouse vas deferens preparations. Members 3-5 of the series possessed irreversible antagonist activity profiles similar to those previously reported for the 14-hydroxy analogues. In contrast, the 14-deoxy-beta-funaltrexamine (14-deoxy-beta-FNA) analogue (6) exhibited a profile of irreversible antagonist activity that differed from that of beta-FNA. It was concluded that the 14-hydroxy group is not essential for irreversible blockage when the electrophile is capable of reacting with a broad spectrum of nucleophiles. However, with a highly selective electrophile such as the fumarate group, the 14-hydroxy function appears to play a role in aligning the molecule to optimize attack by a receptor-based nucleophile.
doi_str_mv 10.1021/jm00389a014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77553676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77553676</sourcerecordid><originalsourceid>FETCH-LOGICAL-a383t-50d121755f50cf00401edd56c71661976c428e487cc8e3d8b85f17a241258cf63</originalsourceid><addsrcrecordid>eNpt0EtvEzEUBWCrApW0ZcUaaRaILsqU67e7rCLaIqUPoBVLy7E9yGFmnNozVfLvcZQoYtGVF-e7R9ZB6AOGcwwEf110AFRdGMDsAE0wJ1AzBewNmgAQUhNB6Dt0lPMCisOEHqJDCpRjKSfo_i72_nkMbZinMHZVXIYYXGX6wfyJfchDZewQXsKwrmJTiS-Y1S44H1fr3rRD8qtyXjmfwospzOcT9LYxbfbvd-8xerr69ji9qWf319-nl7PaUEWHmoPDBEvOGw62AWCAvXNcWImFwBdSWEaUZ0paqzx1aq54g6UhDBOubCPoMfq87V2m-Dz6POguZOvb1vQ-jlnL0k2F3MCzLbQp5px8o5cpdCatNQa9mU__N1_RH3e147zzbm93e5X80y432Zq2Saa3Ie-ZogxTtWH1lpUB_Wofm_RXC0kl148Pv7SE2e_pzx8zfVv86dYbm_UijqmMm1_94D-IJpJb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77553676</pqid></control><display><type>article</type><title>Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Schoenecker, J. W ; Takemori, A. E ; Portoghese, P. S</creator><creatorcontrib>Schoenecker, J. W ; Takemori, A. E ; Portoghese, P. S</creatorcontrib><description>A series of 6,14-dideoxynaltrexones that contain different electrophiles in the 6-position were synthesized and evaluated for nonequilibrium opioid antagonist activity in the guinea pig ileum and mouse vas deferens preparations. Members 3-5 of the series possessed irreversible antagonist activity profiles similar to those previously reported for the 14-hydroxy analogues. In contrast, the 14-deoxy-beta-funaltrexamine (14-deoxy-beta-FNA) analogue (6) exhibited a profile of irreversible antagonist activity that differed from that of beta-FNA. It was concluded that the 14-hydroxy group is not essential for irreversible blockage when the electrophile is capable of reacting with a broad spectrum of nucleophiles. However, with a highly selective electrophile such as the fumarate group, the 14-hydroxy function appears to play a role in aligning the molecule to optimize attack by a receptor-based nucleophile.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00389a014</identifier><identifier>PMID: 3035177</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Animals ; Chemistry ; Cyclazocine - analogs &amp; derivatives ; Cyclazocine - pharmacology ; Dose-Response Relationship, Drug ; Enkephalin, Leucine - analogs &amp; derivatives ; Enkephalin, Leucine - pharmacology ; Enkephalin, Leucine-2-Alanine ; Ethylketocyclazocine ; Exact sciences and technology ; Guinea Pigs ; Heterocyclic compounds ; Heterocyclic compounds with n hetero atom and also o and/or s, se, te hetero atoms ; Mice ; Naltrexone - analogs &amp; derivatives ; Narcotic Antagonists - chemical synthesis ; Narcotic Antagonists - pharmacology ; Organic chemistry ; Preparations and properties ; Receptors, Opioid - drug effects ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 1987-06, Vol.30 (6), p.1040-1044</ispartof><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a383t-50d121755f50cf00401edd56c71661976c428e487cc8e3d8b85f17a241258cf63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00389a014$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00389a014$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8341387$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3035177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schoenecker, J. W</creatorcontrib><creatorcontrib>Takemori, A. E</creatorcontrib><creatorcontrib>Portoghese, P. S</creatorcontrib><title>Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>A series of 6,14-dideoxynaltrexones that contain different electrophiles in the 6-position were synthesized and evaluated for nonequilibrium opioid antagonist activity in the guinea pig ileum and mouse vas deferens preparations. Members 3-5 of the series possessed irreversible antagonist activity profiles similar to those previously reported for the 14-hydroxy analogues. In contrast, the 14-deoxy-beta-funaltrexamine (14-deoxy-beta-FNA) analogue (6) exhibited a profile of irreversible antagonist activity that differed from that of beta-FNA. It was concluded that the 14-hydroxy group is not essential for irreversible blockage when the electrophile is capable of reacting with a broad spectrum of nucleophiles. However, with a highly selective electrophile such as the fumarate group, the 14-hydroxy function appears to play a role in aligning the molecule to optimize attack by a receptor-based nucleophile.</description><subject>Animals</subject><subject>Chemistry</subject><subject>Cyclazocine - analogs &amp; derivatives</subject><subject>Cyclazocine - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enkephalin, Leucine - analogs &amp; derivatives</subject><subject>Enkephalin, Leucine - pharmacology</subject><subject>Enkephalin, Leucine-2-Alanine</subject><subject>Ethylketocyclazocine</subject><subject>Exact sciences and technology</subject><subject>Guinea Pigs</subject><subject>Heterocyclic compounds</subject><subject>Heterocyclic compounds with n hetero atom and also o and/or s, se, te hetero atoms</subject><subject>Mice</subject><subject>Naltrexone - analogs &amp; derivatives</subject><subject>Narcotic Antagonists - chemical synthesis</subject><subject>Narcotic Antagonists - pharmacology</subject><subject>Organic chemistry</subject><subject>Preparations and properties</subject><subject>Receptors, Opioid - drug effects</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0EtvEzEUBWCrApW0ZcUaaRaILsqU67e7rCLaIqUPoBVLy7E9yGFmnNozVfLvcZQoYtGVF-e7R9ZB6AOGcwwEf110AFRdGMDsAE0wJ1AzBewNmgAQUhNB6Dt0lPMCisOEHqJDCpRjKSfo_i72_nkMbZinMHZVXIYYXGX6wfyJfchDZewQXsKwrmJTiS-Y1S44H1fr3rRD8qtyXjmfwospzOcT9LYxbfbvd-8xerr69ji9qWf319-nl7PaUEWHmoPDBEvOGw62AWCAvXNcWImFwBdSWEaUZ0paqzx1aq54g6UhDBOubCPoMfq87V2m-Dz6POguZOvb1vQ-jlnL0k2F3MCzLbQp5px8o5cpdCatNQa9mU__N1_RH3e147zzbm93e5X80y432Zq2Saa3Ie-ZogxTtWH1lpUB_Wofm_RXC0kl148Pv7SE2e_pzx8zfVv86dYbm_UijqmMm1_94D-IJpJb</recordid><startdate>19870601</startdate><enddate>19870601</enddate><creator>Schoenecker, J. W</creator><creator>Takemori, A. E</creator><creator>Portoghese, P. S</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19870601</creationdate><title>Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives</title><author>Schoenecker, J. W ; Takemori, A. E ; Portoghese, P. S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a383t-50d121755f50cf00401edd56c71661976c428e487cc8e3d8b85f17a241258cf63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Animals</topic><topic>Chemistry</topic><topic>Cyclazocine - analogs &amp; derivatives</topic><topic>Cyclazocine - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enkephalin, Leucine - analogs &amp; derivatives</topic><topic>Enkephalin, Leucine - pharmacology</topic><topic>Enkephalin, Leucine-2-Alanine</topic><topic>Ethylketocyclazocine</topic><topic>Exact sciences and technology</topic><topic>Guinea Pigs</topic><topic>Heterocyclic compounds</topic><topic>Heterocyclic compounds with n hetero atom and also o and/or s, se, te hetero atoms</topic><topic>Mice</topic><topic>Naltrexone - analogs &amp; derivatives</topic><topic>Narcotic Antagonists - chemical synthesis</topic><topic>Narcotic Antagonists - pharmacology</topic><topic>Organic chemistry</topic><topic>Preparations and properties</topic><topic>Receptors, Opioid - drug effects</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schoenecker, J. W</creatorcontrib><creatorcontrib>Takemori, A. E</creatorcontrib><creatorcontrib>Portoghese, P. S</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schoenecker, J. W</au><au>Takemori, A. E</au><au>Portoghese, P. S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1987-06-01</date><risdate>1987</risdate><volume>30</volume><issue>6</issue><spage>1040</spage><epage>1044</epage><pages>1040-1044</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>A series of 6,14-dideoxynaltrexones that contain different electrophiles in the 6-position were synthesized and evaluated for nonequilibrium opioid antagonist activity in the guinea pig ileum and mouse vas deferens preparations. Members 3-5 of the series possessed irreversible antagonist activity profiles similar to those previously reported for the 14-hydroxy analogues. In contrast, the 14-deoxy-beta-funaltrexamine (14-deoxy-beta-FNA) analogue (6) exhibited a profile of irreversible antagonist activity that differed from that of beta-FNA. It was concluded that the 14-hydroxy group is not essential for irreversible blockage when the electrophile is capable of reacting with a broad spectrum of nucleophiles. However, with a highly selective electrophile such as the fumarate group, the 14-hydroxy function appears to play a role in aligning the molecule to optimize attack by a receptor-based nucleophile.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>3035177</pmid><doi>10.1021/jm00389a014</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1987-06, Vol.30 (6), p.1040-1044
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_77553676
source MEDLINE; American Chemical Society Journals
subjects Animals
Chemistry
Cyclazocine - analogs & derivatives
Cyclazocine - pharmacology
Dose-Response Relationship, Drug
Enkephalin, Leucine - analogs & derivatives
Enkephalin, Leucine - pharmacology
Enkephalin, Leucine-2-Alanine
Ethylketocyclazocine
Exact sciences and technology
Guinea Pigs
Heterocyclic compounds
Heterocyclic compounds with n hetero atom and also o and/or s, se, te hetero atoms
Mice
Naltrexone - analogs & derivatives
Narcotic Antagonists - chemical synthesis
Narcotic Antagonists - pharmacology
Organic chemistry
Preparations and properties
Receptors, Opioid - drug effects
Structure-Activity Relationship
title Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T08%3A59%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonequilibrium%20opioid%20antagonist%20activity%20of%206,14-dideoxynaltrexone%20derivatives&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Schoenecker,%20J.%20W&rft.date=1987-06-01&rft.volume=30&rft.issue=6&rft.spage=1040&rft.epage=1044&rft.pages=1040-1044&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm00389a014&rft_dat=%3Cproquest_cross%3E77553676%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77553676&rft_id=info:pmid/3035177&rfr_iscdi=true